Brokers Set Expectations for SIGA FY2025 Earnings

SIGA Technologies, Inc. (NASDAQ:SIGA) – Analysts at Edison Inv. Res issued their FY2025 earnings per share estimates for shares of SIGA Technologies in a research report issued to clients and investors on Thursday, March 27th. Edison Inv. Res analyst J. Prakash forecasts that the company will post earnings per share of $0.13 for the year. The consensus estimate for SIGA Technologies’ current full-year earnings is $1.04 per share.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings results on Tuesday, March 11th. The company reported $0.63 earnings per share (EPS) for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The company had revenue of $81.40 million during the quarter.

SIGA Technologies Stock Performance

Shares of SIGA opened at $5.48 on Monday. The stock has a 50 day simple moving average of $5.83 and a 200 day simple moving average of $6.42. SIGA Technologies has a 52-week low of $5.16 and a 52-week high of $12.83. The firm has a market capitalization of $391.47 million, a PE ratio of 4.57 and a beta of 0.98.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Larson Financial Group LLC acquired a new stake in shares of SIGA Technologies during the third quarter worth $30,000. Teacher Retirement System of Texas raised its stake in shares of SIGA Technologies by 19.9% in the 4th quarter. Teacher Retirement System of Texas now owns 12,829 shares of the company’s stock valued at $77,000 after purchasing an additional 2,126 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in shares of SIGA Technologies in the fourth quarter valued at about $78,000. EP Wealth Advisors LLC bought a new stake in shares of SIGA Technologies in the third quarter valued at about $82,000. Finally, Sherbrooke Park Advisers LLC acquired a new position in shares of SIGA Technologies during the fourth quarter worth about $83,000. Institutional investors own 55.40% of the company’s stock.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.